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The HMG-domain-containing transcription factor Sox9 is an important regulator of chondrogenesis, testis formation and development of
several other organs. Sox9 is expressed in the otic placodes, the primordia of the inner ear, and studies in Xenopus have provided evidence that
Sox9 is required for otic specification. Here we report novel and different functions of Sox9 during mouse inner ear development. We show that in
mice with a Foxg1Cre-mediated conditional inactivation of Sox9 in the otic ectoderm, otic placodes form and express markers of otic specification.
However, mutant placodes do not attach to the neural tube, fail to invaginate, and subsequently degenerate by apoptosis, resulting in a complete
loss of otic structures. Transmission-electron microscopic analysis suggests that cell–cell contacts in the Sox9 mutant placodes are abnormal,
although E-cadherin, N-cadherin, and beta-catenin protein expression are unchanged. In contrast, expression of Epha4 was downregulated in
mutant placodes. In embryos with a Keratin-19Cre-mediated mosaic inactivation of Sox9, Sox9-negative and Sox9-positive cells in the otic
ectoderm sort out from one another. In these embryos only Sox9-positive cells invaginate and form one or several micro-vesicles, whereas Sox9-
negative cells stay behind and die. Our findings demonstrate that, in contrast to Xenopus, Sox9 is not required for the initial specification of the
otic placode in the mouse, but instead controls adhesive properties and invagination of placodal cells in a cell-autonomous manner.
© 2008 Elsevier Inc. All rights reserved.Keywords: Sox9; Mouse inner ear development; Otic placode; InvaginationIntroduction
The vertebrate inner ear, which contains the sensory organs
for hearing and balance, develops from an ectodermal placode
adjacent to the posterior hindbrain. In the mouse, otic
development first becomes morphologically apparent at around
the four-somite stage with the thickening of the ectoderm
adjacent to rhombomeres five and six. The generation of a
discernable otic placode takes place by the 10-somite stage.
Between the 13- and 20-somite stage the placode invaginates
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otocyst, neuronal precursor cells delaminate to give rise to the
cochleovestibular ganglion that will innervate the sensory cells
of the inner ear. The otic vesicle then undergoes complex
morphogenetic changes that ultimately generate the architecture
of the adult inner ear (Barald and Kelley, 2004; Kiernan et al.,
2002, and references therein).
Transplantation studies in amphibians and birds have
established that the competence to form an otic vesicle is
initially widely present in the embryonic ectoderm, but
progressively becomes restricted to the otic region as develop-
ment proceeds (Noramly and Grainger, 2002). Development of
the otic placode is thought to be induced by signals from the
cranial paraxial mesoderm and the hindbrain, and members of
the fibroblast growth factor (FGF) family play a central role in
this induction (Phillips et al., 2001; Wright andMansour, 2003a,
b). In addition, Ladher et al. (2005) recently showed that FGF
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most likely by controlling Fgf expression in the mesoderm.
Studies in chick and mouse have also provided evidence for
involvement of Wnt signaling in otic placode induction (Ladher
et al., 2000; Ohyama et al., 2006), although such a role in
zebrafish has been questioned (Phillips et al., 2004). Placode
induction is heralded by the onset of expression of a variety of
genes, including the transcription factors Pax2, Pax8, Dlx5,
Tbx2 and Sox9, which appear in the presumptive placodal
ectoderm before the placode becomes morphologically distinct
(Barald and Kelley, 2004; Kiernan et al., 2002; Noramly and
Grainger, 2002). As the development of the ear progresses to the
otic vesicle stage the expression of these and other markers
becomes confined to defined regions of the otic vesicle, which
give rise to specific structures of the inner ear. This refinement
of the gene expression patterns is also influenced by neighbor-
ing tissues including the notochord and hindbrain (Barald and
Kelley, 2004; Kiernan et al., 2002). Gene targeting experiments
in the mouse have revealed essential functions of an increasing
number of genes expressed in the developing ear (Barald and
Kelley, 2004; Kiernan et al., 2002; Noramly and Grainger,
2002). However, the genetic control of the earliest stages of otic
morphogenesis, the invagination of the otic placode and the
formation of an otic vesicle, is so far poorly understood.
Sox9, a member of the SoxE subgroup of HMG-domain-
containing transcription factors, is expressed in the developing
inner ear in several species (Bagheri-Fam et al., 2006; Liu et al.,
2003; Saint-Germain et al., 2004). In humans, heterozygous
SOX9 mutations are the cause for the skeletal malformation
syndrome campomelic dysplasia, which is characterized by
severe general hypoplasia of the skeleton, XY sex reversal and
defects in several other organ systems including the brain,
pancreas and heart (OMIM 114290). Importantly, campomelic
dysplasia is frequently associated with conductive and sensor-
ineural hearing loss, including malformations of the cochlea
(Houston et al., 1983; Tokita et al., 1979). Indeed, studies in
Xenopus and zebrafish have recently provided evidence for an
essential function of Sox9 in inner ear development. Saint-
Germain et al. (2004) demonstrated that morpholino antisense
oligonucleotide-mediated depletion of Sox9 protein in Xenopus
embryos resulted in loss of early otic markers and failure of otic
vesicle development. They also showed that a hormone-
inducible dominant negative version of Sox9 blocked otic
development during gastrulation, but had little effect on otic
development at later stages, indicating that Sox9 is required for
otic placode specification, but not for subsequent stages of otic
development. Furthermore, loss of Sox9a and Sox9b function in
zebrafish resulted in a complete absence or severe reduction of
the otic vesicle (Liu et al., 2003; Yan et al., 2005). In addition to
these loss-of-function studies, Taylor and Labonne (2005)
recently showed that over-expression of Sox9 in Xenopus can
result in enlarged or ectopic otic vesicles.
In the mouse, the function of Sox9 in otic development has
so far not been examined. Here we used conditional gene
targeting to inactivate Sox9 in the entire prospective otic
placode or only in part of its cells. In contrast to what would
have been expected based on its functions in Xenopus, we findthat in mouse Sox9 is not essential for the initial otic
specification and formation of a morphologically recognizable
otic placode. Instead, we show that Sox9 is cell-autonomously
required for placode invagination, and we provide evidence that
Sox9 controls adhesive properties of placodal cells and regulates
Epha4 expression.
Materials and methods
Mice
Sox9flox/flox mice (Kist et al., 2002) were bred to Foxg1Cre mice (Hebert and
McConnell, 2000) in a mixed background. Foxg1Cre;Sox9flox/+ mice were
viable and fertile and were backcrossed to Sox9flox/flox mice to obtain Foxg1Cre;
Sox9flox/flox embryos. Generation of K19Cre;Sox9flox/flox mice has been
previously described (Barrionuevo et al., 2006). For timed pregnancies,
plugs were checked in the morning after mating, noon was taken as embryonic
day (E) 0.5. Genotyping was carried out on genomic DNA derived from adult
tails or embryonic yolk sacs using established PCR protocols for the Cre allele
(Lecureuil et al., 2002) and for the Sox9 and Sox9flox alleles (Kist et al., 2002).
Histology, RNA in situ hybridization, immunostaining and electron
microscopy
For whole mount RNA in situ hybridization, embryos were fixed, processed
and hybridized as described by Henrique et al. (1995). cDNAs used to generate
riboprobes for Pax2, Pax8 (Dorfler and Busslinger, 1996), Dlx5 (Liu et al.,
1997), Sox8 (Sock et al., 2001), Sox10 (Kuhlbrodt et al., 1998), Tbx2 (Chapman
et al., 1996), Pea3 (Taylor et al., 1997), NeuroD (Gradwohl et al., 2000), Fgf3
(Mansour and Martin, 1988), Epha4 (Mori et al., 1995) and Col2a1 (Rahkonen
et al., 2003) are described in the cited references. To generate a probe for Erm, a
674 bp fragment was amplified by RT-PCR from mouse embryo cDNA using
the primers Erm5′ (TTG GTG CTT CAT GCT CCA CC) and Erm3′ (GTC AGC
ACA GTA ATC TCG GG) and cloned into pCRII-TOPO (Invitrogen). Embryos
for histological analyses were collected in PBS, fixed in Serra (ethanol/37%
formaldehyde/acetic acid, 6:3:1), embedded in paraffin, sectioned at 7 μm and
stained with hematoxylin and eosin. Immunostaining was performed using the
Peroxidase Vectastain ABC Kit (Vector Laboratories) following the manufac-
turer's instructions. For immunofluorescence we used Alexa Fluor 594 rabbit
anti-goat IgG (1:150), biotinylated secondary antibodies (Vector Laboratories)
or the M.O.M kit (Vector Laboratories) and the Fluorescent Avidin Kit (Vector
Laboratories) following the manufacturer's instructions. Primary antibodies
used were: rabbit anti-Sox9 (gift of M. Wegner, Stolt et al. 2003, 1:200), goat
anti-Sox9 (Santa Cruz; sc-17341; 1:50), mouse anti-N-Cadherin (BD Bios-
ciences, Cat# 610920, 1:100), mouse anti-E-Cadherin (BD Biosciences, Cat#
610404, 1:100), mouse anti-beta-Catenin (BD Biosciences, Cat# 610154,
1:100), rabbit anti-N-CAM (Chemicon, Cat# AB5032, 1:100), rabbit anti-Pax2
(Covance, Cat# PRB-276P, 1:100) and goat anti-EphA4 (R&D, Cat# AF641;
1:100). For fluorescence counterstaining of nuclei, DAPI (4′,6-diamidino-2-
phenylindole, Molecular Probes, 100 ng/ml in PBS) was used. Detailed staining
protocols are available upon request. Confocal images were captured using a
Zeiss LSM 510 laser scanning microscope.
For whole mount immunohistochemistry, embryos were collected in PBS,
fixed in methanol:dimethyl sulfoxide (4:1) and processed as described (Nagy et
al., 2003) using a 1:200 dilution of the rabbit anti-Sox9 antibody.
For electron microscopy, embryos were fixed in buffered 2.5% glutaralde-
hyde and 2% osmiumtetroxide, and embedded in Epon 812 resin. Ultra-thin
sections were stained with uranyl acetate and lead citrate and examined in a
Philips CM 10 electron microscope, equipped with a Gatan Bio-scan camera
Model 792.
Analysis of cell proliferation and cell death
For cell proliferation, 7 μm sections were stained with an anti-phospho-
histone H3 antibody (Upstate, Cat# 06-570, 1:200) as described (http://www.
ihcworld.com/_protocols/antibody_protocols/histone_h3_upstate.htm), and
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cell numbers per otic placode was scored.
Detection of apoptotic cells in paraffin sections was performed using either
the In Situ Cell Death Detection Kit (Roche) following the producer's guidelines
or using a rabbit anti-Caspase3-active antibody (R&D Systems, Cat# AF-835) as
described (http://www.ihcworld.com/_protocols/antibody_protocols/caspase3_
r&d_system.htm), but using a 1:100 dilution and the Fluorescent Avidin Kit
(Vector Laboratories) to perform immunofluorescence detection.
Results
Tissue specific inactivation of Sox9 in the early otic ectoderm
It has previously been shown that Foxg1Cre drives Cre
activity into the prospective otic ectoderm and leads to complete
recombination of floxed transgenes in the otocyst (Hebert and
McConnell, 2000; Pirvola et al., 2002). In order to generate
embryos with a conditional inactivation of Sox9 in the
developing inner ear, we therefore crossed mice with a floxed
allele of Sox9 (Sox9flox; Kist et al., 2002) to mice carrying
Foxg1Cre to generate Sox9flox/flox;Foxg1Cre embryos.
Hebert and McConnell (2000) have shown that the genetic
background and the loxP target loci both influence the
recombination pattern obtained with Foxg1-Cre. We therefore
first examined whether Foxg1-Cre mediated recombination
leads to a complete loss of Sox9 expression, and whether
recombination occurs before or after the onset of Sox9-
expression. In Sox9flox/+, Sox9flox/flox, or Sox9flox/+;Foxg1Cre
embryos (hereafter referred to as control embryos), the first
Sox9-positive cells can be detected in the prospective otic area
at the four- to five-somite stage (Figs. 1a, c). By the eight-
somite stage, Sox9 is expressed in a large proportion of the cells
in the otic region, and by the 10-somite stage, the entire nascent
otic placode is Sox9 positive (Figs. 1e, g, i, k, dashed circle). InFig. 1. Recombination takes place before the onset of Sox9 expression in Sox9flox/flox;F
Sox9mutant (mut) embryos. Dashed circles indicate the otic region. In controls, Sox9-
at subsequent stages (e, g). At the same stages, the otic region of Sox9 mutants is lar
detected at the 8-somite stage (f, small arrows). Panels i, j show dorsal views of the em
dashed circle in the mutant embryo shown in panel h is not localized in the otic ectod
10-somite stage mutant and control embryos confirms that the mutant otic placode
crest cells beneath the placode. This staining in neural crest cells is responsible for t
otic placode; the scale bar in panel h corresponds to 150 μm in panels a–h and to 25Sox9flox/flox;Foxg1Cre embryos (hereafter referred to as Sox9
mutant embryos), no Sox9-positive cells were detectable in the
same region at the 10-somite stage or any later stage (Figs. 1h, j,
l, dashed circle, and data not shown). In a small proportion of
Sox9 mutant embryos less than 10 Sox9-positive cells were
transiently detectable at the eight-somite stage (Fig. 1f, small
arrows), indicating that Foxg1-Cre-mediated recombination of
Sox9 largely occurs prior to the onset of Sox9 expression and
that in mutant embryos the vast majority of cells in the otic
region never express Sox9.
Otic placodes are specified in the absence of Sox9 in mice
Recent studies in Xenopus and zebrafish have provided
evidence for an essential function of Sox9 in otic placode
specification (Liu et al., 2003; Saint-Germain et al., 2004). To
see whether Sox9 is required for otic specification also in mice,
we examined the otic region in mutant and control embryos at
the 10–12 somite stage. Hematoxylin/Eosin-stained sections
revealed a thickening of the ectoderm adjacent to the hindbrain
in the presumptive otic region in both control and mutant
embryos (Figs. 2a, a′, b). To further address otic specification of
the thickened ectoderm, we analyzed the expression of markers
of early otic development. FGF signaling is essential for otic
placode induction but also plays important roles at later stages
of otic development. Expression of the Ets-domain transcription
factor genes Erm and Pea3 is dependent on FGF signaling in
many areas of the early embryo and can thus be used as a
reporter for FGF signaling activity (Firnberg and Neubuser,
2002; Raible and Brand, 2001; Roehl and Nusslein-Volhard,
2001). Both genes were expressed in the otic region of mutant
embryos in patterns similar to control embryos, indicating that
FGF signaling is not affected by the absence of Sox9 (Figs. 2c,oxg1Cre embryos. (a–h) Sox9 whole mount immunohistochemistry in control and
positive cells are first detected at the 5–6-somite stage (c), and increase in number
gely devoid of Sox9-positive cells. A few Sox9-positive cells can transiently be
bryos shown in panels g and h to indicate that the diffuse staining visible in the
erm. (k, l) Sox9 immunohistochemistry on sections through the otic placode of
is devoid of Sox9 positive cells, but that Sox9 staining is detectable in neural
he diffuse staining visible in panel h. (nc) Sox9-positive neural crest cells, (op)
0 μm in panels i, j; the scale bar in panel l corresponds to 50 μm in panels k, l.
Fig. 2. Otic specification occurs in the absence of Sox9. (a, b) Hematoxylin/eosin-stained transverse sections through the otic region of control and Sox9mutant (mut)
embryos at the 10-somite stage reveal a thickening of the ectoderm in both embryos (arrowheads). Panel a′ shows a hematoxylin/eosin-stained section through the
same embryo as in panel a but at a level posterior to the otic region to show the thickness of non-otic head ectoderm (arrows) for comparison. (c–j) Whole mount in situ
hybridizations with the indicated probes and at the indicated stages show similar expression of markers of otic specification in mutant and control embryos. (k, l)
Expression of Tbx2 in the otic ectoderm is reduced in the absence of Sox9. In panels c–l, anterior is to the left, arrowheads label the otic placode. The scale bar in panel
b corresponds to 50 μm in panels a, a′, b; the scale bar in panel l corresponds to 400 μm in panels c–l.
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are markers of otic specification and are essential for later stages
of inner ear development (Noramly and Grainger, 2002, and
references therein). At the 9- to 11-somite stage, no difference in
expression of Pax8, Pax2 and Dlx5 was detectable in mutant
and control otic ectoderm (Figs. 2e–j, Figs. S1c–f). Expression
of the transcription factor Tbx2 is also initiated during otic
specification shortly after the onset of Sox9 protein expression
(Fig. 2k, Fig. S2). Its function during inner ear development,
however, has not yet been analyzed. In contrast to Pax8, Pax2
and Dlx5, expression of Tbx2 in mutant embryos was reduced
and confined to a smaller domain at all stages analyzed (Fig. 2l,
Figs. S1g, h). Together, these analyses indicate that a
morphologically distinct otic placode expressing markers of
otic specification can form in the absence of Sox9. However,
Sox9 is already required at this early stage for the initiation of
normal Tbx2 expression.
Sox9 is necessary for otic placode invagination
To follow the development of the inner ear in the absence of
Sox9, we first examined mutant embryos at E9.5 and E11.5. At
E9.5, a small otic placode that had failed to invaginate was
present instead of the otic vesicle found in control littermates
(Figs. 3a, b), and by E11.5, mutants lacked all inner ear
structures (Figs. 1c, d). This finding suggests that otic
development is initiated in the absence of Sox9, but that otic
structures degenerate at later stages. To determine when
phenotypic differences between mutant and control embryos
can first be detected, we examined Hematoxylin/Eosin-stained
sections of the otic region between E8.0 (10-somite stage) and
E9.5 (22-somite stage). At the 10-somite stage, the otic region
in both mutant and control embryos is covered by a thickened
ectoderm, which forms a morphologically distinct placode by
the 13-somite stage (Figs. 3e, f). At this stage in control
embryos, the placode starts to invaginate to form the otic pit(Fig. 3e). Invagination is more pronounced at the 15- and 18-
somite stages (Figs. 3g, i), and an otic vesicle forms by the 22-
somite stage (Fig. 3k). In mutant embryos, the initial
thickening of the ectoderm and the formation of a placode is
normal, but placode invagination is impaired; from the 18-
somite stage on, mutant placodes are also smaller than control
placodes (Figs. 3f, h, j, l).
To assess whether the failure of Sox9 mutant placodes to
invaginate is an indirect consequence of the failure to maintain
placode specific gene expression, we next analyzed the
expression of Pax2, Pax8, Dlx5, Erm, Pea3 and Tbx2 during
the process of placode invagination. At the 15- to 17-somite
stage, expression of Pax2, Dlx5, and Pea3 was maintained in
the non-invaginating Sox9 mutant placodes at levels similar to
those in control placodes (Figs. 3m–r). The same expression
patterns were observed for Pax8 and Erm (not shown). Similar
to the earlier stage, Tbx2 expression was reduced in mutant
placodes (Figs. 3s, t). Thus, the failure of mutant otic placodes to
invaginate seems not to be caused by a loss of otic specification.
To see whether any neuronal precursors for the vestibular
cochlear ganglion are specified in the absence of Sox9, we
compared the expression of NeuroD and Fgf3 in mutant and
control embryos. This analysis suggests that the first neuronal
precursors for the acoustic ganglion are specified in the absence
of Sox9. However, these cells are subsequently lost in most
mutants (Fig. S3).
Sox9 controls adhesive properties of placodal cells
The molecular mechanism of otic placode invagination is
poorly understood and may not be dependent on changes in the
actin cytoskeleton as in other invaginating tissues. Instead,
normal otic placode invagination has been suggested to depend
on an attachment of the placode to the hindbrain (Visconti and
Hilfer, 2002). Such a close association of the dorso-medial part
of the placode with the adjacent brain tissue is clearly visible in
Fig. 3. Foxg1-Cre-mediated recombination of Sox9 blocks otic vesicle formation despite continuous expression of markers of otic specification, and results in loss of
otic structures. (a, b) Whole mount view of the otic primordium of control and Sox9 mutant embryos at E9.5. Note that an otic vesicle has formed in the control
embryo, whereas otic development is arrested at the placode stage in the Sox9mutant. (c, d) Hematoxylin/eosin-stained sections through the otic region of control and
Sox9mutant embryos at E11.5. Note the complete absence of otic structures in the mutant. (e–l) Hematoxylin/eosin-stained sections through the otic region of control
and Sox9 mutant (mut) embryos at the 13- to 22-somite stage (E8.5 to E9.0) reveal a failure of Sox9 mutant placodes to invaginate. Arrowheads in panels e and g
indicate association between the otic placode and the hindbrain, asterisks in panels f and h the absence of this association in mutants. (m–t) Whole mount in situ
hybridizations with the indicated probes and at the indicated stages. Except for Tbx2, patterns in mutant embryos resemble the patterns in control embryos prior to otic
placode invagination. (f) facial (geniculate) ganglion; (hb) hindbrain; (op) otic placode; (ov) otic vesicle; (som) somites; (vc) vestibular cochlear ganglion. The scale
bars in panels a–l correspond to 100 μm. the scale bar in panel t corresponds to 200 μm in panels m–t.
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mutants (Figs. 3f, h, asterisks). Perturbation of the extracellular
matrix including the application of blocking antibodies against
laminin, a component of the basement membrane, can prevent
the association of the otic primordium and the hindbrain,
inhibiting subsequent placode invagination (Visconti and Hilfer,
2002). To assay for changes in the basal lamina, we performed
laminin immunohistochemistry in control and mutant embryos
but could not detect any differences (Figs. 4a, b). To further
assess the integrity of the basal lamina, we examined mutant
and control placodes by transmission electron microscopy, but
again could not detect any differences in the appearance of the
basal lamina (Figs. 4c, d, and insets). However, we detected
major differences in the structure of the placodal epithelium
itself. In control placodes at both the 14- and the 17-somite
stage, cells are tightly packed and very few intercellular spaces
are visible (Figs. 4e, g). In contrast, the mutant epithelium
appears disorganized and contains numerous intercellularspaces, in particular in the basal half of the epithelium (Figs.
4f, h). The disorganized epithelial structure was consistently
seen in all six mutant placodes analyzed and absent from the six
control placodes studied. Higher magnification reveals that
adjacent cells contact each other over extended areas in control
placodes, while contacts between neighboring cells in mutant
placodes are restricted to focal areas (Figs. 4i, j, and insets).
Together, these results indicate that Sox9 controls adhesive
properties of placodal cells.
We therefore next compared the expression of adhesion
molecules in control and mutant placodes by immunofluores-
cence, using antibodies directed against E-cadherin, N-
cadherin, beta-catenin and NCAM. Of these, strong NCAM
staining was detected in the neural tube, notochord, and
somites, but only weak staining close to background levels
was detected in the otic placode or early otic vesicle, and this
staining was similar in mutant and controls (Figs. S4g, h, and
data not shown). For E-cadherin, N-cadherin, and beta-catenin
Fig. 4. Reduced cell–cell contacts in Sox9mutant placodes. (a, b) Antibody staining against laminin reveals the presence of a basal lamina (arrowheads) on the basal side
of control and mutant placodes. (c–j) Transmission electron microscopic pictures of sections through otic placode at the 14- and 17-somite stage. (c, d) show the basal
side of the otic placode of a 14-somite mutant and wildtype embryo. The insets show highmagnification of the boxed regions to reveal the basal lamina. (e–h) In control
placodes, the cells are tightly packed, whereas in mutant placodes at the 14- and 17-somite stage, many intercellular spaces are visible and contacts between neighboring
cells are restricted to small focal areas. Dashed lines indicate the apical (a) and basal (b) limits of the placodes. (i, j) High magnification of a typical contact zone of two
placode cells. Cells in control embryos contact each other over an extended area (i), while contacts betweenmutant cells are focal and interrupted by regions of no contact
(j). Insets show a higher magnification to further demonstrate this difference. Arrows label the cell membranes that are in contact. (hb) hindbrain; (n) nucleus; (op) otic
placode. The scale bar in panel b corresponds to 25 μm in panels a, b, the scale bar in panel d to 1 μm (c, d, i, j), and the scale bar in panel f to 5 μm (e–h).
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placode, but we were unable to detect any difference between
mutant and control placodes (Figs. S4a–f). In contrast, analysis
of protein and RNA expression of the transmembrane receptor
Epha4 revealed a downregulation, but not a complete loss, in
mutant placodes. This downregulation was pronounced on the
protein level but was also detectable on the mRNA level at the
16 somite stage (Figs. 5c–f). In particular, the apical
accumulation of EphA4 protein observed in control placodes
was completely missing in mutant placodes (Figs. 5e, f).
Col2a1 encodes type II collagen, a major component of the
vitreous and cartilage extracellular matrix, and is regulated by
Sox9 in chondrogenesis (de Crombrugghe et al., 2000; Lefebvre
et al., 1997). Col2a1 expression was lost from Sox9 mutant
placodes (Figs. 5g, h), indicating that loss of Sox9 may also
affect the extracellular matrix around the developing ear
placode in addition to affecting cell–cell contacts.
Sox9 mutant placode cells undergo apoptosis
Since Sox9 mutants appear to lose NeuroD-positive cells at
E9.5 and lack all inner ear structures at E11.5, we next
examined whether the mutant otic placodes may degenerate via
apoptosis. Immunostaining using antibody against activated
Caspase3 and TUNEL assays (not shown) revealed no increase
in apoptosis at the 14- to 16-somite stage (not shown), but a
high number of apoptotic cells was present throughout the
mutant otic placodes at the 18–22-somite stage (Fig. 6b). At the
same stage no or only single Caspase3-positive cells at the edgeof the placode were detectable in control embryos (Fig. 6a). In
contrast, analysis of cell proliferation between the 15- and 17-
somite stage revealed no significant differences between control
and mutant placodes (Fig. 6c). Therefore, the size difference
between control and mutant placodes and the eventual loss of
otic tissue in mutant embryos seems to be caused by increased
apoptosis.
Sox9 is necessary for Sox10 expression in the otic placode
Previous studies have shown that the three members of the
SoxE subfamily of Sox genes, Sox8, Sox9 and Sox10, can
function redundantly in regions of co-expression, but also show
cross-regulation (Chaboissier et al., 2004; Stolt et al., 2004;
Taylor and Labonne, 2005). Both Sox8 and Sox10 have been
reported to be expressed in the otic vesicle in the mouse at E9.5
and E10.5, respectively (Britsch et al., 2001; Sock et al., 2001).
The onset of expression of these two genes in the mouse otic
region, however, has not yet been analyzed. In Xenopus, Sox10
expression in the developing otic placode is initiated after Sox9
expression (Taylor and Labonne, 2005). To see whether the loss
of Sox9 affects expression of Sox8 and Sox10, and to evaluate
whether Sox8 and Sox10 might partially compensate for the
loss of Sox9 during otic placode development, we analyzed
expression of Sox8 and Sox10 in Sox9 mutant and control
embryos. In control embryos, weak expression of Sox10 in the
developing otic placode can first be detected around the 13-
somite stage, and increases in strength by the 15-somite stage
(Figs. 7a, c). In Sox9 mutants, no Sox10 expression in the otic
Fig. 6. Sox9 mutant placodes disappear by apoptosis. (a, b) Antibody staining
against activated Caspase3 (green) on sections through the otic region shows a
significant increase in the number of apoptotic cells in Sox9 mutant placodes
(arrowhead). The sections are counterstained with DAPI to label the nuclei.
(Representative examples of serial sections through three mutant and control
embryos are shown.) (c) Antibody staining against phospho-histone H3 reveals
no significant difference between the percentage of mitotic cells in mutant and
control placodes at the 15–17-somite stage (n=10, number of placodes analyzed
for each genotype). The scale bar in panel b corresponds to 100 μm in panels a, b.
Fig. 5. Epha4 and Col2a1 expression is downregulated in Sox9 mutant
placodes. (a–d) Whole mount in situ hybridization with an Epha4 probe reveals
a slightly weaker and less defined Epha4 expression in mutant placodes at the
14 somite stage (a, b), and a strong reduction at the 16 somite stage (c, d). (e, f)
Anti-Epha4 immunofluorescence on sections through the otic placode reveals
robust membrane associated staining in control placodes and only weak staining
in mutant placodes. The mutant placode in panel f is outlined with a dashed line.
(g, h) Whole mount in situ hybridization with a Col2a1 probe. Col2a1
expression can not be detected in mutant placodes at the 15-somite stage.
Arrowheads label the position of the otic placode. (nt) labels the neural tube, r3
and r5 label rhombomers-3 and -5, respectively. The scale bar in (h) corresponds
to 250 μm in panels a–d, and 200 μm in panels g, h; the scale bar in panel f to
50 μm in panels e, f.
Fig. 7. Sox10 is not expressed in Sox9mutant otic placodes. (a–d) Whole mount
in situ hybridization of control (a, c) and Sox9 mutant (b, d) embryos with a
Sox10 probe at the 13- (a, b) and 15-somite (c, d) stage. Arrowheads label the
otic placode. (nc) labels Sox10 expression in neural crest cells. The scale bar in
panel d corresponds to 200 μm in panels a–d.
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Xenopus, Sox10 expression is initiated later than Sox9
expression in the mouse, and is dependent on Sox9 function.
We were unable to detect any Sox8 expression in the developing
otic placode above background level by in situ hybridization or
immunofluorescence at E8.5 (data not shown). Together, these
results rule out the possibility that functional redundancy
between SoxE genes masks any of the functions of Sox9 in early
inner ear development in Sox9 mutants.
Sox9 is cell-autonomously required for otic development
To address whether Sox9 is cell-autonomously required
for otic development, we used Keratin19Cre (K19Cre) mice
which drive Cre expression in a mosaic pattern throughout theepiblast, resulting in recombination of floxed transgenes in 20–
100% of all epiblast cells at E5.5 (Means et al., 2005). Analysis
of Sox9flox/flox;K19Cre/+ embryos (hereafter referred to as Sox9
mosaic embryos) at E9.5 revealed the presence of one or several
micro-vesicles in the otic area (Figs. 8Aa, b). Occasionally,
vesicles of almost normal size were also observed. Interestingly,
both micro-vesicles and larger vesicles are entirely formed by
Sox9-positive cells (Figs. 8Ac–f). At E8.5–E8.75 (10- to 15-
somite stage), the otic placodes of Sox9 mosaic embryos
contain individual Sox9-positive cells, or clusters of such cells
(Figs. 8Ba–d), which invaginate to form micro-vesicles at
E9.25 (Figs. 8Be, f). Occasionally, individual Sox9-positive
cells, which apparently had failed to associate with an
Fig. 8. Phenotype of Sox9 mosaic embryos. (A) Sox9 mosaic embryos form one or several small Sox9-positive otic vesicles. (Aa, b) Whole mount view of the otic
region of a control and Sox9mosaic (mos) embryo at E9.5. Arrowheads label the otic vesicles. (Ac–f) Sections through the otic region of Sox9mosaic embryos at E9.5
and E10.5, stained with a Sox9-specific antibody. Small arrows in panel c label individual Sox9-positive cells among Sox9-negative non-invaginating placode cells.
(B) Sox9 immunofluorescence on sections through the otic region of E8.5 to E9.25 control (Ba, c, e) and Sox9 mosaic (Bb, d, f) embryos. Arrowheads in panel f label
invaginating clusters of Sox9-positive cells. (C) Sox9-positive and -negative cells in E9.0 Sox9 mosaic placodes express Dlx5 and Pax2, but only Sox9-positive cells
invaginate. (Ca) Sox9 immunohistochemistry, (Cb)Dlx5 in situ hybridization on a neighboring section to the section in panel Ca. Arrowheads label invaginating Sox9-
positive cell clusters. (Cc–c″) Double-immunofluorescence against Pax2 (c, red) and Sox9 (c′, green) and overlay (c″). (D) Double-immunofluorescence against
Epha4 (green) and Sox9 (red). (a, b) Overlays, (a′, b′) detection of Epha4 only. Asterisks label Sox9 negative regions of the placodes. (nt), neural tube. (E) Non-
invaginating, Sox9-negative cells in the placode die by apoptosis. TUNEL assay (Ea) and anti-activated Caspase3 immunofluorescence (Eb) on sections through the
otic region of Sox9mosaic embryos. Note that no cell death is detected in the formed otic vesicle (Ea, arrowhead) or invaginating part of the placode (Eb, arrowhead).
The sections shown in panels Ad, B, Eb) were counterstained with DAPI (blue) to label the nuclei. The scale bars in panels A, B, Ca, b, E) correspond to 100 μm, and to
20 μm in panels Cc′–c″, D).
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among the Sox9-negative cells at E9.5 (Fig. 8Ac, arrows). Both
Sox9-positive and Sox9-negative cells in the mosaic otic
placode express the otic markers Dlx5 and Pax2 (Fig. 8C).
However, only Pax2/Sox9-double positive cells of the placode
invaginate (Figs. 8Cc–c″). Invaginating Sox9-positive clustersof cells show a higher level of Epha4 staining and a strong
accumulation of the protein on the apical side of cells which is
missing from Sox9-negative regions of the placode (Fig. 8D).
TUNEL assays and immunostaining for activated Caspase3
show that the Sox9-negative cells in the mosaic placode
subsequently initiate apoptosis (Fig. 8E), similar to what is
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placode (Figs. 6b, d). This analysis of Sox9 mosaic embryos
shows that Sox9 is cell-autonomously required for the
invagination of placodal cells.
Discussion
To address the role of Sox9 in the development of the murine
inner ear, we have conditionally inactivated Sox9 in the
prospective otic region using mice with a Foxg1Cre allele.
This approach reveals novel functions of Sox9 in inner ear
development in the mouse. In the absence of Sox9, otic
placodes form, but the adhesive properties of the placodal cells
are severely compromised and expression of the transmembrane
receptor Epha4 is downregulated. Subsequently, mutant
placodes fail to invaginate and degenerate by apoptosis. By
means of a second Cre line harboring the K19Cre allele we have
created embryos with a mosaic recombination of Sox9 in the
otic region. In these embryos, only Sox9-positive cells
invaginate, indicating that Sox9 is cell-autonomously required
for the invagination of otic placode cells.
Sox9 is necessary for otic placode invagination in mice
Our finding that Sox9 is absolutely required for otic placode
invagination and otic vesicle formation suggests a key function
of Sox9 in this process. In the absence of Sox9, the otic placode
is formed but fails to invaginate, even though Pax2, Pax8 and
Dlx5, markers of otic specification, continue to be expressed.
The failure of otic vesicle formation is thus not a secondary
consequence of a failure to maintain otic specification in the
absence of Sox9.
The molecular mechanism of otic placode invagination is
poorly understood. Previous studies manipulating ATP levels or
disrupting Ca2+ transport, conditions that interfere with the
interaction of cytoskeletal actin and myosin, revealed no effect
on otic placode invagination (Hilfer et al., 1989). It was
therefore suggested that otic placode invagination may not be
dependent on the formation of a contractile actin ring as in other
invaginating tissues (Pilot and Lecuit, 2005). Instead, it has
been proposed that normal otic placode invagination requires
attachment of the placode to the hindbrain (Visconti and Hilfer,
2002). In support of this idea, perturbation of the extracellular
matrix by injecting blocking antibodies against laminin or
heparansulfate proteoglycans into chick embryos prevented the
association of the otic primordium and the hindbrain and
inhibited subsequent placode invagination (Moro-Balbas et al.,
2000; Visconti and Hilfer, 2002). However, other studies had
shown that otic placodes isolated from 10-somite stage quail
embryos and transplanted to the lateral trunk of chick hosts form
otic vesicles at very high frequency even though they are
positioned far away from the neural tube (Groves and Bronner-
Fraser, 2000). The importance of association of the otic placode
with the hindbrain for invagination and vesicle formation in
avian embryos is thus currently unclear.
Even less is known in the mouse. The analysis of Gata3
mutants provided evidence that otic vesicle formation can occureven when contact of the otic placode with the neural tube is
reduced (Lillevali et al., 2006). We detected a close association
of the dorso-medial part of the placode with the adjacent brain
tissue in control mouse embryos, which is absent in Sox9
mutants. But in light of the Gata3 mutant phenotype it is likely
that the missing attachment of Sox9-mutant placodes to the
hindbrain is not the primary reason for the block of placode
invagination and subsequent otic vesicle formation. This idea is
further supported by our finding that in Sox9 mosaic embryos,
groups of Sox9-positive cells invaginate and form micro-
vesicles without any contact to the hindbrain.
Our analysis of Sox9 mosaic embryos shows that Sox9 is
cell-autonomously required for invagination of early placodal
cells. The observation that invaginating micro-vesicles are
exclusively composed of Sox9-positive cells suggests that
Sox9-positive and Sox9-negative cells sort out from one
another. A similar segregation of Sox9-positive and negative
cells has also been observed during chondrogenesis in
chimaeric embryos consisting of Sox9−/− and Sox9+/− cells.
In these embryos, Sox9−/− and Sox9+/− cells were intermingled
in the early skeletogenic mesenchyme, but Sox9-deficient cells
were then excluded form mesenchymal condensations and
cartilage primordia (Bi et al., 1999). Such a sorting-out behavior
would be expected if Sox9 controls the adhesive properties of
cells. Consistent with such a function, transmission electron
microscopic pictures of Sox9-mutant otic placodes revealed
reduced cell–cell contacts. These changes in epithelial organi-
zation are detected more than 12 h before the onset of apoptosis
in mutant placodes, and are therefore not a consequence of
epithelial cell death. Since the adhesive properties of cells are
important for epithelial morphogenesis (Pilot and Lecuit, 2005)
it is possible that the failure of otic vesicle formation is a
consequence of reduced adhesion between otic placode cells in
Sox9 mutants.
In light of the observed changes in cell–cell contacts and the
sorting of Sox9-positive and negative cells in mosaic placodes,
the downregulation of EphA4 protein expression in Sox9
mutants is of particular interest. Members of the Eph receptor
tyrosin kinase family and their membrane-tethered ligands, the
ephrins, have key roles in the regulation of cell adhesion and
cell migration during development (Klein, 2004; Poliakov et al.,
2004). In the hindbrain, complementary expression of Epha4
and ephrinB ligands and bi-directional signaling at the interface
is thought to control rhombomere-specific cell sorting and the
establishment of sharp boundaries between cell populations that
do not intermingle (Cooke andMoens, 2002; Xu et al., 1999). In
addition, Eph/ephrin signaling has also been implicated in the
regulation of cell segregation during somitogenesis and
skeletogenesis (Durbin et al., 1998, 2000; Compagni et al.,
2003; Davy et al., 2004). It is therefore possible that Eph/ephrin
signaling also regulates the segregation of placode precursor
cells from non-placode cells, and cell–cell adhesion during otic
placode morphogenesis, with Sox9 as an upstream regulator.
Epha4 mutant mice have been generated but have no inner
ear defects (Dottori et al., 1998; Helmbacher et al., 2000).
However, this is not surprising, since Eph receptor functions are
often redundant due to overlapping expression patterns of
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towards ephrin ligands. Loss of function studies in single genes
have likewise so far not revealed a role of Eph/ephrin signaling
in somite or hindbrain segmentation (Klein, 2004; Poliakov et
al., 2004). It will therefore be important to clarify which other
members of the Eph family and which of the ephrin ligands are
expressed during inner ear development and how their
expression is affected by the absence of Sox9.
In addition, although the EM pictures and laminin stainings
show no difference in the basement membrane of control and
Sox9-mutant placodes, we can not exclude that loss of Sox9
also affects the composition of the extra-cellular matrix on the
basal side of the placode, and this could indirectly affect the
adhesive properties of the placodal cells. Such a function of
Sox9 in regulating the extra-cellular matrix is well established
for chondrogenesis. There, Sox9 regulates the expression of
extracellular matrix components such as type II collagen (de
Crombrugghe et al., 2000; Lefebvre et al., 1997), and Col2a1 is
also down-regulated in the Sox9-mutant otic placodes, although
no defects for in inner ear development have been reported for
Col2a1 knock out mice (Li et al., 1995).
Sox9 mutant placode cells undergo apoptosis
Around E9.0, about 12 h after the first changes in the
morphogenetic behavior of Sox9-mutant placodes can be seen,
the non-invaginated placodal cells of Sox9 mutants start to be
eliminated by apoptosis. Apoptosis of misplaced cells is a
frequent phenomenon in development. It is therefore very likely
that the observed cell death is an indirect consequence of the
changes in epithelial organization or the failure of placode
invagination. However, a direct role of Sox9 in promoting cell
survival in the otic placode can not be excluded. Previous
studies in avian embryos addressing otic placode commitment
showed that placodes transplanted to the trunk region survived
far away from the hindbrain, whether they formed an otic
vesicle or not (Groves and Bronner-Fraser, 2000). It is thus
unlikely that an increased distance of the placode from a source
of survival signals in the hindbrain is responsible for the
observed apoptosis.
Apoptosis has also been reported after inactivation of Sox9
in trunk neural crest cells and limb mesoderm (Akiyama et al.,
2002; Cheung et al., 2005). But also in these tissues, it is unclear
whether Sox9 has a direct and cell autonomous effect as a
survival factor or if apoptosis is an indirect consequence of
other defects.
Species-specific requirement of Sox9 in otic development
In Xenopus, depletion of Sox9 protein using morpholino
antisense oligonucleotides causes the loss of early otic placode
markers and prevents the formation of an otic vesicle (Saint-
Germain et al., 2004). This study suggests that Sox9 has a role
in the initial specification of the otic placode. In sox9a- and
sox9b-compromised zebrafish, otic vesicles are missing or
reduced to vestiges, and Pax2 is not expressed in the otic region.
A detailed analysis of the phenotype, however, was notperformed, so that it is unclear whether otic placode specifica-
tion, or subsequent placode morphogenesis and survival is
affected (Liu et al., 2003; Yan et al., 2005). In contrast, the
formation of a morphologically distinct placode and the normal
expression of markers of otic placode specification (Pax2,
Pax8, and Dlx5) and of FGF signaling (Pea3 and Erm) in our
Sox9 mutants demonstrate that the specification of the otic
placodes in the mouse does not require Sox9. Thus, there appear
to be species-specific differences in the requirement for Sox9 in
inner ear development between Xenopus and mouse. These
differences correlate with differences in the timing of the onset
of Sox9 expression: In Xenopus and also zebrafish, Sox9
expression in the presumptive otic placode already starts during
neurulation (Liu et al., 2003; Saint-Germain et al., 2004),
whereas in the mouse Sox9 protein can first be detected at the 5-
somite stage. Our results furthermore exclude that Sox8 and
Sox10, the two other members of the SoxE group of the Sox
gene family, substitute for mouse Sox9 in otic specification.
Both genes have been shown to be expressed during mouse otic
development (Britsch et al., 2001; Sock et al., 2001; Watanabe
et al., 2000) and recent studies in Xenopus have shown that
misexpression of either Sox9 or Sox10 results in the formation
of enlarged or ectopic otocysts, demonstrating that both factors
are equally potent to promote inner ear formation (Taylor and
Labonne, 2005). However, we show that expression of both
genes starts only after otic placode specification, and that there
is a cross regulation between Sox9 and Sox10 in mice such that
Sox10 is not expressed in Sox9-deficient otic placodes.
Therefore, if Sox9 has any function in the formation of the
otic placode in the mouse, then redundant pathways involving
genes other than SoxE genes must exist.
In summary, our analysis reveals an important novel role of
Sox9 in controlling otic placode invagination in the mouse. In a
recent study on the transcriptional control of Sox9 expression,
we have identified an enhancer element conserved between
human, mouse and pufferfish, which mediates Sox9 expression
in the inner ear (Bagheri-Fam et al., 2006). Characterization of
the transcription factors activating this otic enhancer on the one
hand, and identification of the transcriptional targets of Sox9 in
the murine otic placode on the other hand, may both contribute
to a better understanding of the molecular regulation of otic
placode invagination.
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